Vdex Diabetes - Medicare Primary Care in Alamogordo, NM

Vdex Diabetes is a medicare enrolled primary clinic (Nurse Practitioner) in Alamogordo, New Mexico. The current practice location for Vdex Diabetes is 916 N White Sands Blvd, Alamogordo, New Mexico. For appointments, you can reach them via phone at (575) 488-2720. The mailing address for Vdex Diabetes is Po Box 836, Alamogordo, New Mexico and phone number is (575) 488-2720.

Vdex Diabetes is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1972528891. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (575) 488-2720.

Contact Information

Vdex Diabetes
916 N White Sands Blvd
Alamogordo
NM 88310-6926
(575) 488-2720
(575) 488-2721

Primary Care Clinic Profile

Full NameVdex Diabetes
SpecialityNurse Practitioner
Location916 N White Sands Blvd, Alamogordo, New Mexico
Authorized Official Name and PositionAmber Bryant (EXECUTIVE ADMINISTRATOR)
Authorized Official Contact5754882720
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Vdex Diabetes
Po Box 836
Alamogordo
NM 88311-0836

Ph: (575) 488-2720
Vdex Diabetes
916 N White Sands Blvd
Alamogordo
NM 88310-6926

Ph: (575) 488-2720

NPI Details:

NPI Number1972528891
Provider Enumeration Date07/13/2006
Last Update Date05/04/2022

Medicare PECOS Information:

Medicare PECOS PAC ID6901702976
Medicare Enrollment IDO20031210000463

News Archive

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

​Two patients with amyotrophic lateral sclerosis (ALS) have received stem cell injections to their spinal cords at the University of Michigan Health System - the first two to receive the experimental injections in Michigan as part of a national clinical trial.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Vdex Diabetes such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1972528891NPI-NPPES
20559330MedicaidNM
NM007E60OtherNMBCBS GROUP NUMBER

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 98-288 (New Mexico)Secondary
261Q00000XClinic/center (* (Not Available))Secondary
363L00000XNurse Practitioner (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Vdex Diabetes acts as a billing entity for following providers:
Provider NameGilberto Heredia
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1649299942
PECOS PAC ID: 4880590850
Enrollment ID: I20051107000646

News Archive

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

​Two patients with amyotrophic lateral sclerosis (ALS) have received stem cell injections to their spinal cords at the University of Michigan Health System - the first two to receive the experimental injections in Michigan as part of a national clinical trial.

Read more Medical News

› Verified 2 days ago

Provider NamePeter Brock
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1992298665
PECOS PAC ID: 5698009843
Enrollment ID: I20191227000362

News Archive

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

​Two patients with amyotrophic lateral sclerosis (ALS) have received stem cell injections to their spinal cords at the University of Michigan Health System - the first two to receive the experimental injections in Michigan as part of a national clinical trial.

Read more Medical News

› Verified 2 days ago

Provider NameClaudia E Enriquez
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1356985170
PECOS PAC ID: 5991131674
Enrollment ID: I20200129002009

News Archive

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

​Two patients with amyotrophic lateral sclerosis (ALS) have received stem cell injections to their spinal cords at the University of Michigan Health System - the first two to receive the experimental injections in Michigan as part of a national clinical trial.

Read more Medical News

› Verified 2 days ago

Provider NameTara L Greenwood
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1215530217
PECOS PAC ID: 2769897206
Enrollment ID: I20210216001767

News Archive

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

​Two patients with amyotrophic lateral sclerosis (ALS) have received stem cell injections to their spinal cords at the University of Michigan Health System - the first two to receive the experimental injections in Michigan as part of a national clinical trial.

Read more Medical News

› Verified 2 days ago

Provider NameGretchen Olds
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1528006095
PECOS PAC ID: 9133131782
Enrollment ID: I20220330000921

News Archive

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

​Two patients with amyotrophic lateral sclerosis (ALS) have received stem cell injections to their spinal cords at the University of Michigan Health System - the first two to receive the experimental injections in Michigan as part of a national clinical trial.

Read more Medical News

› Verified 2 days ago

News Archive

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

Dermatologists urge athletes to be aware of most common skin infections

Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.

FDA approves Phase II trial to study effect of injected stem cells in ALS patients

​Two patients with amyotrophic lateral sclerosis (ALS) have received stem cell injections to their spinal cords at the University of Michigan Health System - the first two to receive the experimental injections in Michigan as part of a national clinical trial.

Read more News

› Verified 2 days ago


Nurse Practitioner in Alamogordo, NM

Desert Skies Family Practice Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1101 9th St Ste B, Alamogordo, NM 88310
Phone: 575-437-1113    Fax: 575-437-1777
Simplicity Health Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 74 Forsyth Road, Alamogordo, NM 88310
Phone: 575-405-9453    
Alamogordo Clinic Ltd
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1410 Aspen Drive, Alamogordo, NM 88310
Phone: 505-437-7000    Fax: 505-434-6288
Family Practice Of Alamogordo
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1909 Cuba Ave, Suite 4, Alamogordo, NM 88310
Phone: 575-443-6262    
Chandi Bankston, D.o.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1315 12th St, Alamogordo, NM 88310
Phone: 505-437-5716    Fax: 505-437-5733
Advancednp
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1102 9th St, Alamogordo, NM 88310
Phone: 575-446-5333    
Michael S Mishkin Md Pc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1315 12th St, Alamogordo, NM 88310
Phone: 575-437-5716    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.